Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a broader rehab programme help people with low vision live better?

NCT ID NCT07827040

Symptom relief Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 18, 2026 · Last updated Sep 18, 2026

Summary

Researchers are testing whether a multidisciplinary vision rehabilitation programme improves quality of life more than low vision training alone for adults with visual impairment. The trial enrolls 1,000 Cantonese-speaking adults in Hong Kong aged 18 to 80 who have a clinical diagnosis of low vision and a stable eye condition. Participants are assigned to one of three groups: a waitlist control, low vision training only, or a broader programme that adds counselling, exercise training, and home assessment with modifications. The intervention lasts eight weeks with four on-site sessions, and researchers measure general and vision-related quality of life as the main outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a multidisciplinary vision rehabilitation programme combining low vision training, exercise, counselling, and home modifications
What this could lead to
If the programme works, it could give adults with low vision a clearer path to better daily function and quality of life. It may also help shape how vision rehabilitation services are organised.
What could go wrong
This is a behavioural programme, not a drug, so results depend on how well participants stick with the training. Benefits may fade after the programme ends, and findings from Hong Kong may not apply everywhere.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18 and 80 years * Community-dwelling in Hong Kong * Cantonese Speaker * Clinical diagnosis of low vision (best-corrected visual acuity \<6/18; and/or field loss of \< 20 degree) * Stable ocular condition for ≥ 3 months * Owns a smartphone * Not currently participating in any vision rehabilitation programme * Willing to participate and commit for at least 6 months to 12 months * Provides informed consent Exclusion Criteria: * Living in a nursing home/ institutionalized * Self-reported severe cognitive impairment or HK-MoCA-VI cut off score of 12 * Self-reported severe hearing impairment * Uncontrolled systemic ocular diseases/ neurological or psychiatric conditions * Immobility caused by physical impairment * Refuse to provide written informed consent * Participating in another vision rehabilitation programme during the trial period

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adults are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vision disorder Vision, Low

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adults Low vision digital assistance Visual impairments

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • School of Optometry, The Hong Kong Polytechnic University

    RECRUITING

    Kowloon, Hung Hom, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.